Press releases

Press release
Additional remetinostat phase II data will be presented at the International Investigative Dermatology meeting on May 18 and 19

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that additional data from the phase II study of remetinostat in...

Read more
Press release
Resolutions at the Annual General Meeting in Medivir on 3 May 2018

Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing directorThe...

Read more
Press release
Number of shares and votes in Medivir

Stockholm, Sweden - Medivir AB (”Medivir” or the ”Company”) (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes...

Read more
Press release
MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2018

Significant events during the quarter The holders of series A shares have notified the Company that they will convert all their...

Read more
Press release
Data from the MIV-711 initial phase IIa study will be presented at the OARSI World Congress on April 27

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that data from the initial phase IIa study of MIV-711, which...

Read more
Press release
New preclinical data on MIV-818 will be presented at the AACR Annual Meeting in April

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new preclinical data for MIV-818 will be presented during the...

Read more
Press release
Medivir’s Annual Report for 2017 is published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2017 now is available at the...

Read more
Press release
Notice of Annual General Meeting of Medivir AB (publ)

The shareholders in Medivir AB are hereby summoned to the Annual General Meeting on Thursday 3 May 2018 at 2 p.m....

Read more
Press release
Conversion of all class A shares in Medivir to class B shares – prospectus published

Stockholm, Sweden - Medivir AB (”Medivir” or the ”Company”) (Nasdaq Stockholm: MVIR) today announces that the prospectus, which has been prepared...

Read more
Press release
The Nomination Committee´s proposal for new Board of Directors to the Annual General Meeting 2018

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces the Nomination Committee’s proposal for a new Board of Directors to...

Read more
Press release
Medivir Announces Departure of Chief Medical Officer

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that John Öhd, Chief Medical Officer at Medivir, has decided to...

Read more
Press release
New preclinical data on MIV-818 accepted for presentation at EASL’s HCC Summit in March

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new preclinical data for MIV-818 will be presented at the...

Read more